Most Favored Nation Model Stakeholder Considerations
Avalere Essential Voice
English - December 07, 2020 17:39 - 12 minutes - 17.2 MBMedicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Social Determinants of Health – The Importance of Data, Part 2
Next Episode: What's Next for Telehealth?
In this episode of Start Your Day with Avalere, our policy experts discuss the Most Favored Nation (MFN) drug pricing model due to begin on January 1.